T T Yoshikawa, N K Fujita. Show Affiliations »
Abstract
Mesh： See more » Antitubercular Agents/adverse effectsAntitubercular Agents/metabolismAntitubercular Agents/pharmacologyAntitubercular Agents/therapeutic useChemical PhenomenaChemistryEthambutol/therapeutic useHumansIsoniazid/therapeutic useKineticsMycobacterium tuberculosis/drug effectsRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis, Pulmonary/drug therapy
Substances： See more » Antitubercular AgentsEthambutolIsoniazidRifampinStreptomycin
Year: 1982 PMID： 6801402 DOI： 10.1016/s0025-7125(16)31454-7
Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456